30 Stocks Moving in Wednesday's Pre-Market Session

Gainers

• Party City Holdco Inc. PRTY rose 34.4% to $1.74 in pre-market trading after the company announced it regained compliance with NYSE continued listing standards.
• Endologix, Inc. ELGX shares rose 33.8% to $0.4150 in pre-market trading after surging over 22% on Tuesday.
• Intersect ENT, Inc. XENT rose 26.7% to $17.60 in pre-market trading.
• UP Fintech Holding Limited TIGR shares rose 19.4% to $6.55 in pre-market trading.
• VBI Vaccines Inc. VBIV rose 16.2% to $3.90 in pre-market trading after gaining around 21% on Tuesday.
• BioCryst Pharmaceuticals, Inc. BCRX rose 12.7% to $6.10 in pre-market trading after gaining over 9% on Tuesday.
• Corvus Pharmaceuticals, Inc. CRVS rose 12.4% to $5.57 in pre-market trading. Corvus Pharmaceuticals shares climbed over 80% on Tuesday following an announcement concerning its foray into COVID-19 treatment.
• Electrameccanica Vehicles Corp. SOLO rose 12.3% to $4.68 in pre-market trading after declining over 19% on Tuesday.
• AMC Entertainment Holdings Inc AMC rose 10.4% to $4.56 in pre-market trading after a Wall Street Journal report said the company is nearing a deal that will help it avoid bankruptcy, at least in the short term.
• ObsEva SA OBSV rose 10.1% to $3.28 in pre-market trading after dropping over 8% on Tuesday.
• Nikola Corporation NKLA rose 9.4% to $43.99 in pre-market trading. JP Morgan upgraded Nikola from Neutral to Overweight and announced a $45 price target.
• U.S. Well Services, Inc. USWS rose 8.8% to $0.49 in pre-market trading following a 5% drop on Tuesday.
• TechnipFMC plc FTI rose 8.7% to $7.73 in pre-market trading after declining 8% on Tuesday.
• Mmtec, Inc. MTC rose 8.1% to $1.48 in pre-market trading.
• CHF Solutions, Inc. CHFS rose 8% to $0.6445 in pre-market trading after climbing around 12% on Tuesday.
• Futu Holdings Limited FUTU rose 7.2% to $32.98 in pre-market trading.
• Ideanomics, Inc. IDEX rose 7.1% to $1.35 in pre-market trading after dropping over 11% on Tuesday.
• GenMark Diagnostics, Inc. GNMK rose 6.7% to $16.62 in pre-market trading after the company reported it sees preliminary Q2 sales of roughly $40.1 million. The company said "COVID-19 positively impacted second quarter placements and revenue."

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• VIVUS, Inc. VVUS fell 28.2% to $0.58 in pre-market trading after the company filed for Chapter 11 bankruptcy protection.
• MOGU Inc. MOGU fell 16.6% to $4.94 in pre-market trading after jumping 105% on Tuesday.
• Fuel Tech, Inc.FTEK fell 13.3% to $0.98 in pre-market trading. Fuel Tech shares jumped 25% on Tuesday after the company announced it was awarded multiple equipment orders totaling $2.2 million.
• Gevo, Inc. GEVO fell 10% to $0.63 in pre-market trading after gaining over 6% on Tuesday.
• CBAK Energy Technology, Inc. CBAT shares fell 9.9% to $1.00 in pre-market trading following a 16% declined on Tuesday.
• Annovis Bio, Inc. ANVS fell 9.3% to $6.15 in pre-market trading. Annovis Bio shares climbed around 77% on Tuesday after the company received Central Institutional Review Board approval to initiate 15 site Phase 2 study in 68 Parkinson's and Alzheimer's patients.
• Viveve Medical, Inc. VIVE fell 8.8% to $0.5884 in pre-market trading. Viveve shares jumped 14% on Tuesday after the company reported the FDA approval to conduct PURSUIT trial for improvement of stress urinary incontinence.
• Aeterna Zentaris Inc. AEZS fell 8% to $0.4753 in pre-market trading. Aeterna Zentaris reported closing of $12 million public offering.
• Superconductor Technologies Inc. SCON fell 7.5% to $0.4331 in pre-market trading. Allied Integral United reported a 12.7% active stake in Superconductor Technologies.
• Aclaris Therapeutics, Inc. ACRS shares fell 6.8% to $1.65 in pre-market trading after the company announced it submitted an Investigational New Drug Application to the FDA for its ATI-1777.
• Diffusion Pharmaceuticals Inc. DFFN fell 6.6% to $0.8610 in pre-market trading. On Tuesday, Diffusion Pharmaceuticals filed IND for international Phase 1b/2b COVID-19 clinical program with TSC.
• 89bio Inc ETNB shares fell 6.5% to $30.90 in pre-market trading after the company priced its upsized 2.6 million share public offering of common stock at $27.50 per share.